Personal information

No personal information available

Activities

Collapse all

Works (5)

Long-Term Monitoring of the Antibody Response to a SARS-CoV-2 Infection

Diagnostics
2021-10-16 | Journal article
DOI: 10.3390/diagnostics11101915
Contributors: Václav Šimánek; Ladislav Pecen; Hana Řezáčková; Ondřej Topolčan; Karel Fajfrlík; Dalibor Sedláček; Robin Šín; Monika Bludovská; Petr Pazdiora; David Slouka et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

BAI1 as a Prognostic Marker of Clear Cell Renal Cell Carcinoma (ccRCC)

Anticancer Research
2021-09 | Journal article
DOI: 10.21873/anticanres.15255
Part of ISSN: 0250-7005
Part of ISSN: 1791-7530
Source: Self-asserted source
Hana Rezackova

The Potential of Mir-499 Plasmatic Level As A Biomarker Of Obstructive Sleep Apnea Syndrome

Biomarkers in Medicine
2021-08 | Journal article
DOI: 10.2217/bmm-2020-0826
Contributors: David Slouka; Jindra Windrichova; Hana Rezackova; Katerina Houfkova; Radek Kucera; Vaclava Cerna; Tomas Kostlivy; Ondrej Topolcan; Martin Pesta
Source: check_circle
Crossref

Five Commercial Immunoassays for SARS-CoV-2 Antibody Determination and Their Comparison and Correlation with the Virus Neutralization Test

Diagnostics
2021-03-25 | Journal article
DOI: 10.3390/diagnostics11040593
Part of ISSN: 2075-4418
Source: Self-asserted source
Hana Rezackova

The Level of Preoperative Plasma KRAS Mutations and CEA Predict Survival of Patients Undergoing Surgery for Colorectal Cancer Liver Metastases

Cancers
2020-08-27 | Journal article
DOI: 10.3390/cancers12092434
Part of ISSN: 2072-6694
Source: Self-asserted source
Hana Rezackova
How many people are using ORCID?